Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
169 hedge funds and large institutions have $1.46B invested in Amedisys in 2016 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 59 reducing their positions, and 23 closing their positions.
24% more capital invested
Capital invested by funds: $1.18B → $1.46B (+$280M)
22% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 23
2% more funds holding
Funds holding: 165 → 169 (+4)
3% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 59
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
42% less call options, than puts
Call options by funds: $3.11M | Put options by funds: $5.36M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$31.4M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$30.9M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$11.5M |
| 4 |
Renaissance Technologies
New York
|
+$10.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$57.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.9M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.5M |
| 4 |
HAI
Hennessy Advisors Inc
Novato,
California
|
-$7.67M |
| 5 |
Morgan Stanley
New York
|
-$7.37M |
AMED Hedge Fund Activity: Q1 2016 in Review
169 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2016, worth a combined $1.46B — up 24% from $1.18B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new AMED positions and 23 closed out — a net gain of 5 holders — while 61 added to existing stakes and 59 trimmed.
The largest buyer was William Blair Investment Management, opening a new position worth an estimated $31.4M. The largest seller was North Tide Capital, cutting an estimated $57.9M.
- 169 institutional investors held Amedisys (AMED) as of Q1 2016, up from 165 in Q4 2015.
- Funds reported $1.46B of Amedisys stock for Q1 2016, up 24% quarter-over-quarter.
- 28 funds opened new Amedisys positions in Q1 2016 and 23 closed out, a net change of +5 holders.
- The largest Amedisys buyer in Q1 2016 was William Blair Investment Management, an estimated $31.4M added.
- The largest Amedisys seller in Q1 2016 was North Tide Capital, an estimated $57.9M sold.
Based on aggregated 13F filings for Q1 2016.